Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Sanchez

Showing results (251-260 of 319) with videos related to

Pageof 32
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
Plos Medicine|September 1, 2012
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settingsThomas B Campbell, Laura M Smeaton, N Kumarasamy, et al.
Journal of the International AIDS Society|July 2, 2025
The science at HIVR4P 2024: The era of choice in biomedical HIV preventionBeatriz Grinsztejn, Victor Appay, Linda-Gail Bekker, et al.
Nature Medicine|June 2, 2024
Cell-free DNA for the detection of kidney allograft rejectionOlivier Aubert, Cindy Ursule-Dufait, Romain Brousse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional StudyNishi Suryavanshi, Matthew Murrill, Amita Gupta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney OutcomesMeggan Mackay, Maria Dall'Era, Joanna Fishbein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
A versatile platform for generating engineered extracellular vesicles with defined therapeutic propertiesKevin Dooley, Russell E McConnell, Ke Xu, et al.
Arthritis Research & Therapy|May 26, 2025
Functional work disability from the perspectives of persons with systemic lupus erythematosus: a qualitative thematic analysisBehdin Nowrouzi-Kia, Aaron S Howe, Anson Li, et al.
The New England Journal of Medicine|October 21, 2011
Timing of antiretroviral therapy for HIV-1 infection and tuberculosisDiane V Havlir, Michelle A Kendall, Prudence Ive, et al.
Pageof 32

Showing results (251-260 of 319) with videos related to

Sort By:
Pageof 32
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2023
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant TuberculosisSonya Krishnan, Xingye Wu, Soyeon Kim, et al.
Plos Medicine|September 1, 2012
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settingsThomas B Campbell, Laura M Smeaton, N Kumarasamy, et al.
Journal of the International AIDS Society|July 2, 2025
The science at HIVR4P 2024: The era of choice in biomedical HIV preventionBeatriz Grinsztejn, Victor Appay, Linda-Gail Bekker, et al.
Nature Medicine|June 2, 2024
Cell-free DNA for the detection of kidney allograft rejectionOlivier Aubert, Cindy Ursule-Dufait, Romain Brousse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional StudyNishi Suryavanshi, Matthew Murrill, Amita Gupta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Establishing Surrogate Kidney End Points for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney OutcomesMeggan Mackay, Maria Dall'Era, Joanna Fishbein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2019
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis DiseaseAmita Gupta, Susan Swindells, Soyeon Kim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
A versatile platform for generating engineered extracellular vesicles with defined therapeutic propertiesKevin Dooley, Russell E McConnell, Ke Xu, et al.
Arthritis Research & Therapy|May 26, 2025
Functional work disability from the perspectives of persons with systemic lupus erythematosus: a qualitative thematic analysisBehdin Nowrouzi-Kia, Aaron S Howe, Anson Li, et al.
The New England Journal of Medicine|October 21, 2011
Timing of antiretroviral therapy for HIV-1 infection and tuberculosisDiane V Havlir, Michelle A Kendall, Prudence Ive, et al.
Pageof 32